The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 372

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-22-1_005

تاریخ نمایه سازی: 20 مهر 1398

چکیده مقاله:

Objective(s): Leishmaniasis is one of the main health problems in developing countries, caused by intracellular protozoan parasites of the Leishmania genus. Although research has been successful in discovering vaccines and anti-parasitic drugs like antimony compounds, their side effects like high toxicity, prolonged regeneration, etc., have raised the replacement importance of natural products with antioxidant and antibacterial properties. It can be said that an appropriate alternative to this is the ozonated olive oil. Ozone by introducing O2 in involved tissues and bloodstream could degrade parasite amastigotes and lead to cleared leishmaniasis infections. So, the present study aimed to evaluate the effect of ozonated olive oil in Iranian leishmaniasis patients compared to glucantime, a choice drug for the treatment of Leishmaniasis.Materials and Methods: Thirty patients with confirmed leishmaniasis lesions were included and divided into two groups, 15 cases as control and 15 cases as test with lesions of 30–50 mm2 in diameter. The control group received glucantime intralesionally and the test group ozonated olive oil plus glucantime, 2 times daily.Results: The mean of lesion size was (50.94±33.20) before and (15±14.34) after treatment in control (P<0.00) and (50.88±31.74) before and (9.93±14.18) after treatment in the test group (P<0.00). Moreover, the mean course of therapy was 10.4(±1.84) weeks and 8.93(±2.15) weeks in control and test groups, respectively (P=0.636). Significant differences were reported in lesion size after treatment between the two groups (P<0.00).Conclusion: Data suggested ozonated olive oil can have synergistic effects with glucantime in the treatment of cutaneous leishmaniasis.

نویسندگان

Maryam Aghaei

Skin Diseases and Leishmaniasis Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Shahrzad Aghaei

Department of Molecular Medicine, School of Advanced Technologies,Shahrekord University of Medical Sciences, Shahrekord, Iran

Fatemeh Sokhanvari

Skin Diseases and Leishmaniasis Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Nazli Ansari

Skin Diseases and Leishmaniasis Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand ...
  • Fata A, Salehi G, Rafatpanah H, Mousavi bazzaz M, Mohaghegh ...
  • Desjeux P. The increase in risk factors for leishmaniasis worldwide. ...
  • David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatolo Ther ...
  • Hashemi N, Mohaghegh M, Hashemi M, Azami M, Mortazavidehkordi N, ...
  • Mirzaei F, Bafghi AF, Mohaghegh MA, Jaliani HZ, Faridnia R, ...
  • Pulvertaft RJ, Hoyle GF. Stages in the life-cycle of Leishmania ...
  • Machowetz A, Poulsen HE, Gruendel S, Weimann A, Fito M, ...
  • Al-Waili NS. Mixture of honey, beeswax and olive oil inhibits ...
  • Perona JS, Arcemis C, Ruiz-Gutierrez V, Catala A. Effect of ...
  • Rodriguez-Rodriguez R, Herrera MD, Perona JS, Ruiz-Gutierrez V. Potential vasorelaxant ...
  • Marquez-Martin A, De La Puerta R, Fernandez-Arche A, Ruiz-Gutierrez V, ...
  • Fernandez-Arche A, Marquez-Martin A, de la Puerta Vazquez R, Perona ...
  • Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med ...
  • Rennecker JL, Mariñas BJ, Owens JH, Rice EW. Inactivation of ...
  • Carvajal G, Branch A, Michel P, Sisson SA, Roser DJ, ...
  • Mandhare M, Jagdale D, Gaikwad P, Gandhi P, Kadam V. ...
  • Elvis AM, Ekta JS. Ozone therapy: A clinical review. J ...
  • Torrentino-Madamet M, Almeras L, Desplans J, Le Priol Y, Belghazi ...
  • Wickramanayake GB, Rubin AJ, Sproul OJ. Inactivation of Giardia lamblia ...
  • Casimiro E, Calheiros J, Santos FD, Kovats S. National assessment ...
  • Valacchi G, Bocci V. Studies on the biological effects of ...
  • Bulynin V, Ermakova A, Glukhov A, Mozhurov I. Wound treatment ...
  • Gajendrareddy PK, Sen CK, Horan MP, Marucha PT. Hyperbaric oxygen ...
  • Leask A, Abraham DJ. The role of connective tissue growth ...
  • Nogales CG, Ferreira MB, Lage-Marques JL. Comparison of the antimicrobial ...
  • Sadatullah S, Mohamed NH, Razak FA. The antimicrobial effect of ...
  • Sechi LA, Lezcano I, Nunez N, Espim M, Dupre I, ...
  • Travagli V, Zanardi I, Valacchi G, Bocci V. Ozone and ...
  • Travagli V, Zanardi I, Bocci V. Topical applications of ozone ...
  • Kyriazis JD, Aligiannis N, Polychronopoulos P, Skaltsounis A-L, Dotsika E. ...
  • Elamin MH, SS AL-M. Leishmanicidal and apoptotic activities of oleuropein ...
  • Velikaya V, Gribova O, Musabaeva L, Startseva Z, Simonov K, ...
  • Rosul MV, Patskan BM. Ozone therapy effectiveness in patients with ...
  • Patel PV, Kumar V, Kumar S, Gd V, Patel A. ...
  • Rajabi O, Sazgarnia A, Abbasi F, Layegh P. The activity ...
  • Kim HS, Noh SU, Han YW, Kim KM, Kang H, ...
  • Patel PV, Gujjari SK. The morphometrical and histopathological changes which ...
  • Kumar T, Arora N, Puri G, Aravinda K, Dixit A, ...
  • نمایش کامل مراجع